Weight-loss medication has taken the world by storm and helped many overweight people. But for some, significant weight loss ...

Actimed Therapeutics’ anti-catabolic and pro-anabolic transforming agent, S-pindolol benzoate receives US & European patents: London, UK Friday, February 7, 2025, 16:00 Hrs [IST ...

Biotech startup Tensegrity Pharma announced on the 31st raising 150 million yen in seed funding. This round saw participation from Mitsubishi UFJ Capital, bringing their cumulative seed round ...

A $3.2 million grant from the National Institutes of Health is empowering University of Houston researchers to tackle Rhabdomyosarcoma, a malignant soft tissue sarcoma that has a higher incidence in ...

Wendy Yeh, M.D. Chief Medical Officer, NGM Bio Dr. Yeh will oversee the continued clinical development of NGM Bio’s key ...

In a recent study, researchers demonstrated that Z526, a novel dithiocarbamate-like compound, mitigates cancer-associated cachexia (CAC) both in vitro and in vivo.

In cancer-associated cachexia, elevated TNF-α and IL-6 exacerbate muscle and fat loss by regulating multiple metabolic signaling pathways, which could be ameliorated by Z526's suppression of NF-κB ...

Z526- a novel dithiocarbamate-like compound reverses cancer associated cachexia via mitigating NF-B signaling and oxidative ...

Salk Institute researchers have identified a key protein that may help users of GLP-1 drugs such as Ozempic and Wegovy ...

Teresa Zimmers, professor of cell, developmental and cancer biology at the Oregon Health & Sciences University School of Medicine, at 12:55 p.m. Wednesday, Jan. 29, on Zoom.